Effect of the British warning on contraceptive use in the General Medical Service in Ireland

Irish Medical Journal

Volumn 91, Issue 6, 1998, Pages 202-203

  Williams, D ^a   Kelly, A ^a   Carvalho, M ^a   Feely, J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADOLESCENT; ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CONTRACEPTION; CONTRACEPTIVE METHODS--SIDE EFFECTS; CONTRACEPTIVE USAGE; DEVELOPED COUNTRY; DISTRIBUTIONAL ACTIVITIES; DOSE RESPONSE; DRUG CONTRAINDICATION; EUROPE; FAMILY PLANNING; FEMALE; HUMAN; INTERPERSONAL COMMUNICATION; IRELAND; MALE; METHOD ACCEPTABILITY--CHANGES; METHODOLOGY; MIDDLE AGED; NORTHERN EUROPE; ORAL CONTRACEPTIVES, COMBINED--SIDE EFFECTS; ORAL CONTRACEPTIVES--SIDE EFFECTS; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PRESCRIPTIONS--CHANGES; PROGRAM ACTIVITIES; PROGRAMS; RESEARCH REPORT; STUDIES; THROMBOEMBOLISM; UNITED KINGDOM;

COMMUNICATION; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTIVE METHODS--SIDE EFFECTS; CONTRACEPTIVE USAGE; DEVELOPED COUNTRIES; DISTRIBUTIONAL ACTIVITIES; EUROPE; FAMILY PLANNING; IRELAND; METHOD ACCEPTABILITY--CHANGES; NORTHERN EUROPE; ORAL CONTRACEPTIVES, COMBINED--SIDE EFFECTS; ORAL CONTRACEPTIVES--SIDE EFFECTS; ORGANIZATION AND ADMINISTRATION; PRESCRIPTIONS--CHANGES; PROGRAM ACTIVITIES; PROGRAMS; RESEARCH METHODOLOGY; RESEARCH REPORT; STUDIES; UNITED KINGDOM;

ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL, HORMONAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GREAT BRITAIN; HUMANS; IRELAND; MALE; MEDROXYPROGESTERONE; MIDDLE AGED; PROGESTERONE; THROMBOEMBOLISM;

EID: 0032248534     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Committee on safety of medicines, Combined oral contraceptives and thromboembolism. London CSM, 1995
2. WHO collaborative study of cardiovascular disease and steroid hormone contraception. Effect of different progestogens in low oestrogen oral contraceptives on venous thromboembolic disease Lancet 1995 364 1582-88.
3. Jick H, Jick SS; Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and non-fatal venous thromboembolism in women using oral contraceptives with different progestagen components. Lancet 1995; 346 1589-93.
4. Bloemenkamp KWM, Rosendaal FR, Helmerhost FM, Buller H, Vandenbroucke JP Enhancement by factor V Leiden mutation on risk of deep-vein thrombosis associated with oral contraceptives containing a third generation progesterone. Lancet 1995; 346: 1593-96
5. Irish Medicines Board Drug Safety Newsletter. 'Third Generation' Oral Contraceptives Dublin: December 1995
6. Irish Medicines Board Drug Safety Newsletter, Oral Contraceptives, safety concerns. Dublin: May 1996
7. Iverson O, Nilsen S Abortions increased by nearly 8% in Norway BMJ 1996; 313 letter 363-364
8. Murty J, Firth S. Contraceptive effectiveness may be being sacrificed for safety BMJ 1996, 313 letter 363
9. Ketting E CSM's advice will harm women s health worldwide. BMJ 1996, 312 letter 576
10. Hope S 12% of women stopped taking their pill immediately they heard CSM s warning BMJ 1996 letter 576
11. Ferguson J, Jenkins M General practitioners in England prescribed second generation pills instead. BMJ 1996, 313 letter 363
12. Suissa S, Blais L, Spitzer WO, Cusson J, Lewis M, Heinemarm L First-time use of newer oral contraceptives and the risk of venous thromboembolism Contraception Sep 1997 56(3)114-6.
13. Farmer R, Lawrenson R, Thompson C, Kennedy J, Hambleton Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet, 349:83-88